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The uterine cervix plays a vital role in maintaining pregnancy and an equally important role in allowing parturition to occur.
Progesterone,eitherendogenouslyproducedorsuppliedexogenously,supportsthefunctionofthecervixinsustainingintrauterine
pregnancy, and the withdrawal of progesterone, either through natural processes or pharmacologic intervention, leads to delivery
which underscores the importance of the progesterone’s biological activities manifest in normal gestation and pregnancy that
ends prematurely. Research crossing many scientiﬁc disciplines has demonstrated that progesterone is a pleotropic compound that
aﬀects the cervix through cytoplasmic and membrane receptors with profound eﬀects on cellular and molecular functions that
inﬂuence inﬂammatory cascades and extracellular matrix, both of which have consequences for parturition. Beyond the local cell
and molecular biology of progesterone, it has systemic eﬀects of relevance to pregnancy as well. This paper examines the biology
of the cervix from its gross to cellular structure and biological activities of its cell and molecular processes that may be aﬀected by
progesterone. The implications of these processes for preterm birth are explored, and direction of current research is in relation to
translational medicine implications for diagnostic, prognostic, and therapeutic approaches to threatened preterm birth.
1.Introduction
Yellon and coworkers [1] have aptly referred to the cervix
as the “gatekeeper for pregnancy.” This does not minimize
the role of uterine and placental biology, maternal-fetal
interactions, and the integrity of the fetal membranes,
nor does it abnegate neurobiological aspects of pregnancy
maintenance[2].Thecontinuingconcernforthepersistently
high rates of preterm birth that plague research-rich and
research-poor countries [3] strategies that have a reasonable
level of evidence for preventing untimely birth is a topic
that deserves investigation. Indeed, as recent research has
indicated that progesterone administered systemically [4]
or locally [5] to forestall preterm birth (albeit with limita-
tions and qualiﬁcations) has intensiﬁed the importance of
understanding the relationship between progesterone and
the cervix of the pregnant uterus.
The intentional focus on the biology of the cervix in this
paper is supported by the recent review by Word et al. [6]
who make the point that current research has conﬁrmed that
the remodeling of the cervix is a slowly developing process
that occurs over a length of time and that the progressive
changes in the cervix precede the uterine contractions by
several weeks in normal pregnancy.
The gatekeeper function of the cervix is simultaneously
structural and biological, and the breadth of its functions
and interactions with other anatomic structures and biologic
or pharmacologic mediators should not be ignored. How-
ever, in this paper, we propose to review what is known
about the role of the cervix as a mechanical structure
and how progesterone inﬂuences this function. We will
next consider the cellular and molecular actions that are
inherent in maintaining pregnancy and in responding to
changing hormonal conditions during gestation. Finally, the
concept of inﬂammation as the ﬁnal common pathway to
parturition will be examined both from the standpoint of
term and preterm pregnancy and options for altering the
inﬂammatory processes that play a role in preterm birth.2 Infectious Diseases in Obstetrics and Gynecology
2. StructuralandFunctionalAttributesof
the Cervix
At the gross level, the change of the cervix early in pregnancy
from a dense, rigid tissue with a closed os to parturition
with a softened consistency, shortened distance from os
to membranes, and eﬀacement at the time of labor, is
well known and usually understood as a process that
predominantly involves changes in collagen. Recent studies
have elaborated that concept and suggest a process that is
complex and nuanced. Many of the studies related to the
precise processes involved in the pregnancy-related changes
to the cervix have necessarily involved animal model studies,
especially when experimental protocols have been involved.
In considering the role of gonadal steroids in cervical
biology and in particular the central role of progesterone in
maintaining pregnancy, there is support for the concept that
rodents provide a reasonable model for cell biology of the
cervix, particularly as it applies to the extracellular matrix
[1]. A recent report suggests that tissue-related changes in
human subjects may be evaluated through ﬁne needle biopsy
of the cervix and that these biopsies were not accompanied
by signiﬁcant risk [7]. Based on this paper, it is likely that
many of the observations derived from rodent studies may
be veriﬁed or replicated in human research participants.
Another gross aspect of the cervical geometry through
pregnancy is the shortening of the cervix. This has taken
on a very important signiﬁcance in recent years as the
availability of transvagininal ultrasonography has been able
to document the length of the cervical canal, and the length
of the closed portion of the cervical canal relates to risk
of preterm birth as summarized by recent reviews [8, 9].
Remodelingofthecervixandshorteningofthecervicalcanal
may be harbingers of precipitous birth both on the basis of
loss of mechanical support, and also because the bacterial
ﬂora of the lower genital tract is moved closer to the fetal
membranes overlaying the internal os.
As we will discuss later, the connection between amniotic
infection and inﬂammatory reactions has been linked to
preterm birth, and the role of shortened cervix is likewise
associated. For example, Vaisbuch et al. correlated short
cervix with amniotic inﬂammatory reaction, though not
necessarily positive amniotic ﬂuid culture, and 40% of
thosewithintra-amnioticinﬂammationdeliveredwithinone
week [10]. Even in the absence of documented infection,
the inﬂammatory process might develop in response to
bacterial exposure and possibly due to translocation of
bacteria. Romero’s group indicated that the development of
sonographically identiﬁable collections of material referred
to as “amniotic sludge” accumulated above the internal os
and was associated with adverse pregnancy outcome [11].
Though the concept of sludge is relatively new, some of the
developing literature on the topic suggests that sludge may
contain bacteria as suggested by a report on the presence
of sludge among short-cervix patients who also had intra-
amniotic Fusobacterium nucleatum [12]. This favors the idea
that the short cervix may enhance bacterial exposure. Of
course, it did not take the invention of ultrasound for
observant physicians to associate midtrimester ripening of
the cervix with preterm birth risk and the idea of providing
additional support for the mechanical attributes of the
cervix in maintaining pregnancy. The idea of the cervix as
mainly a mechanical gateway to parturition naturally leads
to the concept of mechanical reinforcement of the cervix to
overcome the functional deﬁciency in the structure. Cerclage
has been used for decades to address this issue and has
always been somewhat controversial, and it has fallen in and
out of favor through the history of modern obstetrics. It is
beyond the scope of this paper to review the current role of
cerclage in obstetrical practice, but it does raise the related
possibility that the cellular and molecular remodeling of
the cervix through physiologic processes (term or preterm)
may diﬀer among individual patients. It is also possible that
there may be a distinction between mechanical insuﬃciency
of the cervix and premature labor which is mediated by
irreversiblebiochemicalchangesallowingfortheﬁndingthat
indomethacin may stratify patients with short cervix [13].
Thus, cerclage is not uniformly eﬀective in preventing
delivery before 35 weeks, and with suﬃcient understanding
of epidemiologic and biochemical markers involved in
patients with sonographically documented short cervix, the
application of cervical cerclage may be applied on a more
individualized basis with improved outcomes. For example,
cervical funneling may remain after cerclage, and one study
foundthatwhenitdoes,thepatienthasahigherlikelihoodof
delivering preterm than when funneling is not present [14].
Beyond the geometry, physical strength, pliability of the
cervix, and the shape of the cervical canal during pregnancy,
the cellular structure and molecular biology of the cervical
cells will necessarily contribute to the mechanical attributes.
It is recognized that progesterone has a demonstrable eﬀect
on the rate of cervical shortening and preterm delivery when
administered to women admitted for preterm labor between
25and33+6weeksgestation[15].Thecellularandmolecular
eﬀects of progesterone on cervical biology will therefore be
reviewed.
3. CellBiology of the Cervix
Several cellular components of the cervix deserve mention.
Importantly, the muscular character of the cervix is in
many ways subordinate to the extracellular matrix in which
connective tissue is a key to its mechanical strength. In a
thorough review of the extracellular matrix of the body of
the cervix, House et al. [16] emphasize that two aspects
of the cervical changes during pregnancy (softening and
ripening) should be individually understood as the former
relates to the consistency of the cervical tissue which is
progressively changing through pregnancy, and the latter
relates to the load-bearing capacity of the cervix at the
end of gestation. The ripening has been associated with the
inﬂammatory activities which are commonly described as
the ﬁnal common pathway to parturition.
The signiﬁcance of ﬁbrillar collagen as the key compo-
nentofthemechanicalproperties ofthecervixisemphasized
by its abundance and diminution in cervical insuﬃciency
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cells, and smooth muscle. The softening part of the remodel-
ing process involves these cells over the course of pregnancy.
In addition to collagen, other stromal components of the
cervix include water which increases slightly throughout
pregnancy, proteoglycans which appear to have a role
in tissue hydration and association with collagen ﬁbrils
decreases during pregnancy, and elastin which may play a
complementary role to collagen [16].
Many of the experimental studies on the composi-
tion and changes through the cervical remodeling process
have been established in rodents in which gene knockout
experiments [18], steroid hormone receptor blockade [19],
or gene expression experiments [20] can be more readily
and ethically accommodated than among humans. Thus,
hyaluronan,whichisalargeanionicpolysaccharideregulated
by progesterone that has been studied extensively in rodents
[21], is associated with proinﬂammatory activities inter-
action with collagen and glycopeptide versican. Timmons
and Mahendroo [21] suggest that t he versican/hyaluron
structures interpolated into collagen make the tissue more
compliant that when collagen dominates. At parturition,
hyaluronidase is increased in the cervix and cervical mucus,
and the resulting breakdown of hyaluron allows for massive
disaggregation of the biopolymers allowing for signiﬁcant
dilation/eﬀacement of the cervix.
4. ProgesteroneandCervicalFunction
Regulation of these elements of the body of the cervix
involves, among other mediators, progestational agents. The
presence and absence of progesterone and progestational
agents are both critical at various stages of pregnancy. Main-
tainingpregnancyatthelevelofplacenta,uterinequiescence,
and limiting cervical inﬂammatory reactions are well-known
attributes of progesterone. Progesterone withdrawal is a key
element of parturition and is accompanied by a diﬀerent
set of biological cascades. As noted previously, attention
is focused on progesterone because of recently concluded
research on its potential use in preventing premature birth.
Nevertheless, it is important in exploring the biological
eﬀects of progesterone to recognize its integration into
systems that include multiple steroid and peptide hormones
and tissues other than the cervix.
As collagen plays an important role in the compliance
and tensile strength of the cervix and progression toward a
compliant and ultimately ripened cervix, the role of proges-
terone is of interest. The cervix begins softening through a
process of continuously advancing collagen reorganization
of the collagen ﬁbrillar structure accompanied by decreasing
levels of collagen accessory proteins, thrombospondin 2, and
tenascin C as well as lysyl hydroxylase which is important
in collagen crosslinking as demonstrated in mouse studies
[22]. This report found that collagen content did not change
during pregnancy, but its organization did. The practical
importance of these elements are illustrated by the ﬁnding
thatthrombospondin2deﬁciencyinmiceresultsinuntimely
cervical ripening [23]. It is unclear whether progesterone has
a direct regulatory eﬀect on thrombospondin 2 expression
in the cervix, but in myometrial cell culture, progesterone
increased thrombospondin 1 expression, while estradiol
decreased it [24].
Tenascins are extracellular matrix proteins that also
contribute to the strength of tissues such as the cervix, and
while not all details of its role in the cervix throughout
pregnancy are known, in mouse models of endometrial
stroma culture, it was found that tenascin C expression
was positively controlled indirectly by progesterone, possibly
through IL-1 alpha or prostaglandins [25]. Tenascin C
decreases during pregnancy in mice consistent with the
cervical softening process and is consistent with the collagen
disorganization process.
Another aspect of collagen disorganization is related to
enzymatic action by the matrix metalloproteinases (MMPs).
The MMP family of enzymes, including collagenases, gelati-
nases, and elastases, have recognized signiﬁcance in tissue
remodelingeventsincludingintrauterineimplantation,inva-
sion by tumors, and vascular problems. The source of the
MMPs is often inﬂammatory cells, but these enzymes may
also be elaborated by other cell types. Studies of rat cervix
during pregnancy found MMP2 to be present in the stroma
but not epithelium in term pregnancy, but its role in cervical
ripening was unclear as it was also present in nonpregnant
rats [26], and MMP8 appeared after parturition and was
associated with neutrophil inﬁltration. Fibroblast cultures
made from partal women showed elevated (compared to
nonpregnantwomen)MMP1,3[27].Theauthorsattributed
theﬁbroblast-derivedMMPstosignalingfrominﬂammatory
cellspresentduringlabor.Whilethereisinformationindicat-
ing the upregulation of MMP9 by estrogen and progesterone
by the uterine stroma [18], no comprehensive inventory of
MMPsandrelationshiptosteroidhormonelevelsisavailable.
Further complicating the picture is the fact that the net
enzyme activity within tissues is the result of a balance
between the enzyme and its inhibitors [28].
The role of hyaluronidase and hyaluronon, and versican
andanMMP,ADAMTS1,wasnotedpreviously[21].Asindi-
cated by the work of House et al. [18], progestational agents
are mediators of hyaluronan expression. Hyaluronan in the
cervical tissues results from a balance between synthesis
(hyaluronan synthase 2) and degradation (hyaluronidase).
Hyaluronan synthase activity is suppressed by proges-
terone according to mouse studies [29] while hyaluronidase
activity remains unchanged. Another glycosaminoglycan,
versican, is also regulated by hormonal control [30],
and its disintegrin, ADAMTS1, which disrupts hyaluonan-
versican complexes also is increased by progesterone
[31].
Finally, it should be noted that attention has also been
drawn to the peptide hormone relaxin which is highly
conserved among various species and has been associated
with increased compliance in the pubic symphysis of animals
[32]a sw e l la sc h a n g e si ne x t r a c e l l u l a rm a t r i x[ 33]. However,
an attempt to establish its relationship to progesterone in
pregnant rat studies indicated that progesterone apparently
exerts control over the relaxin [34], and in a human cell line
(JAR cells) medroxyprogesterone acetate upregulated relaxin
expression [35].4 Infectious Diseases in Obstetrics and Gynecology
A complex and as yet incomplete picture of how the
extracelluar matrix of the cervix and its individual macro-
molecular components are regulated throughout pregnancy
and parturition undoubtedly implies a very key role for
progesterone. Some progesterone-regulated processes are the
result of direct eﬀects, while others may be mediated though
inﬂammatory mediators or peptide hormones or enzymes
from stromal or inﬂammatory cells. Despite the variety
and complexity of coordinated events related to birth, it is
clear that the physiologic processes involved in labor and
delivery involve the functional withdrawal of progesterone.
As reviewed by Mesiano et al. [36], this may be accomplished
by a change in nuclear progesterone receptor expression,
though details of the process are yet to be elucidated in
humans and may as suggested by Mendelson [37]i n v o l v e
progesterone inactivity due to molecular interaction with
transcription factors, changes in progesterone receptor co-
regulatorexpression,metabolicmodiﬁcationofprogesterone
in stromal tissues, or expression of diﬀerent isoforms of the
receptorthatleadstoinhibitionofprogesteroneactivity.This
paper emphasized the important fact that in addition to
the traditional mechanism of progesterone action through
nuclear receptors, much of the complexity of progesterone
action results from nongenomic activities of progesterone
both at the level of the cervix and in other tissues such as
myometrium.
5. PrematureCervicalRipening
Cervical ripening is an element of preterm as well as term
birth but raises the question as to the underlying mechanism
of premature ripening and the corollary question of whether
the mechanisms involved in premature ripening diﬀer or are
the same as those involved in term ripening of the cervix.
Much of our current understanding has been gained through
research completed in the past few years.
As mentioned before, the onset of labor has been
associated with the presence of elevated cytokines, the
inﬂux of neutrophils, and activation of macrophages which
has led to the often-repeated statement that inﬂammation
appears to be the ﬁnal common pathway for parturition.
For example, cervical biopsies from uninfected term and
preterm laboring women showed upregulation of Il-6, Il-8,
and MCP-1 with elevated peripheral white counts and C-
reactive protein whichwasinterpreted asa commonpathway
i np r e t e r ma sw e l la st e r ml a b o r[ 38]. Nevertheless, it is
possible that there are nuances in the initial trigger for
cervical ripening and mediators involved in the process at
diﬀerent gestational ages. The use of microarray analysis
allowed the comparison of gene expression in mice at
diﬀerent gestational ages with premature delivery induced
by the progesterone receptor inhibitor mifepristone, or
by lipopolysaccharide [39]. Although the results indicated
more than 300 genes were diﬀerentially regulated between
experimental groups, the authors concluded that, indeed,
there were distinct molecular mechanisms between term and
preterm cervical ripening. A more focused evaluation of
cervicalbiopsy-derivedpro-andanti-inﬂammatorycytokine
expression in women [40] who were in preterm or term
labor, not in labor, or not pregnant, concluded that there
were diﬀerences between preterm labor related to infection
versus noninfected and overall diﬀerences between term
and preterm cervical cytokine expression pointed to anti-
inﬂammatory cytokines as key actors.
New information on the distinctive attributes of term
and preterm cervical biology during parturition and dif-
ferences in initiation of ripening process was published
by Holt and coworkers in 2011 [41], emerged from a
very comprehensive study of the mouse cervix wherein
birth was elicited by lipopolysaccharide or mifepristone.
The authors stated that their data indicate that preterm
birth is not simply an accelerated form of physiologic
cervical ripening. They also suggested that there were
diﬀerences in inﬂammatory inﬁltrates with monocytes
dominating progesterone receptor antagonism, while neu-
trophils dominated lipopolysaccharide-mediated premature
ripening. Early induction of prostaglandin was related to
Ptgs(Cox)2 with LPS and Ptgs(Cox)1 with mifepristone.
While this report emphasized that many aspects of mouse
cervical ripening are conserved in humans, there is further
need to determine if these important ﬁndings hold for
human cervical physiology.
There is general agreement that some cases of premature
cervical ripening and hence preterm birth are related to
infection and that infection may account for up to one-third
of preterm births. The inﬂammatory response elicited by
infectious agents has also become the accepted mechanism
for preterm birth. In contrast, the remaining instances of
preterm birth are attributed to less deﬁned causes such
as genetic background of the mother or fetus, environ-
mental factors, intercurrent illness, or health conditions. In
consideration of the focus on the cervix and the role of
progesterone in maintaining and ending pregnancy, several
recently discovered genetic associations that may have an
impact on cervical ripening are reviewed.
Genetic associations with preterm birth imply, in some
instances, potential eﬀects on the cervix. Day and coworkers
[42], reasoning that myometrial quiescence involves the
activity of K+ channels and gene polymorphisms in mouse
SK channel gene KCNN3 (small conductance calcium-
activated potassium channel subfamily N, member 3) related
to preterm and postdate birth, studied this gene in 602
families with at least 1 preterm birth. They associated six
SNPs in this gene with preterm birth. While the role of this
gene is mainly believed related to myometrial activity, the
ion channels are involved in responses to stretch elicit Cox-
2 activity and prostaglandin activity which aﬀect the cervix
as well as the myometrium. Thus, this genetic association
may be predicted to have relevance to the cervix and,
as the authors state, to other tissues as well. Anum and
coworkers pursued an interesting approach to identifying
candidate genes which may associate with preterm birth
[43]. Reasoning that heritable diseases with genetic defects
in connective tissue should result in preterm birth if these
genes have a potential relationship, they were able to ﬁnd a
substantial number of genes that could contribute to cervical
incompetence.Infectious Diseases in Obstetrics and Gynecology 5
6. CervicalEpithelium
The cervical epithelium is composed of squamous cells
on the external portion of the cervix and cuboidal cells
within the os. The latter are more exposed during eﬀace-
ment. Because of the abundant microﬂora of the lower
female genital tract the cervical epithelial cells will be
exposedtoindigenousbacteriathroughoutpregnancyandto
exogenously acquired bacteria on speciﬁc occasions such as
coitusduringpregnancy.Becauseoftheinﬂammatoryevents
that are associated with preterm delivery, it is appropriate
to consider whether the cervical epithelium is strictly a
barrier to invasion by microorganisms, and whether the
barrier function diﬀers between squamous and columnar
epithelium. Further, it is important to understand whether
the cervical epithelia are able to sense and respond to
exposure to microorganisms.
With regard to the barrier function of the epithelia,
a recent report elaborates on the intercellular attachments
of the squamous and cuboidal cells [44]. The endocervical
columnar cells were found to have tight junctions that
excluded ﬂuorescently labeled IgG, whereas the superﬁcial
layers of the exctocervix lacked classical cell adhesion
mechanisms and were permeable to labeled macromolecular
probes, but below the apical-most layers, strong exclusionary
junctions were present.
Despite the physical barrier, there are of course microor-
ganisms that have the ability to invade through cells includ-
ing a number of sexually transmitted pathogens, such as
Neisseria gonorrhea and Chlamydia trachomatis,w h i c hw i l l
not be reviewed here. Of perhaps greater importance to the
topic at hand is the possibility that the cervical epithelial
cells can sense and respond to microbial molecules, and
this response can elicit or at least contribute to initiation
of the inﬂammatory cascade. Although immortalized tissue
culture cells were used, Herbst-Kralovetz et al. demonstrated
that endocervical and ectocervical epithelial cells possessed
a full complement of toll-like receptors, and liganding these
receptors with appropriate agonists could elicit a cytokine
response [45], but some of the responses were not robust.
An earlier study indicated that TLR4 was absent or perhaps
deﬁcient in endocervical cells, but CD14 coreceptor activity
allowed these cells to respond to exposure to bacterial
lipopolysaccharide [46].
The toll-like receptors are membrane-associated pattern
recognition receptors (PRRs) that are foundational to innate
immunity as they bind to commonly expressed microbial
components(pathogenicity-associatedmolecularpatternsor
PAMPs) and transduce signals that elicit cytokine produc-
tion. Less well studied are the NOD (nuclear oligomerization
domain) receptors which are cytosolic receptors that bind
bacterial cell wall components and also transduce signals
that result in cytokine expression. The NODs are found in
epithelial cells and would be expected to be part of the
genital tract epithelium innate defense. Indeed, they have
been found in functional form in endometrial epithelium
[47] and in trophoblast cells [48] and would be anticipated
to be present in endocervix, though this has not yet been
conﬁrmed.
Together, these reports conﬁrm the ability of cervical
epithelial cells to respond to microbial substances with
cytokine reactivity. While it may make little diﬀerence
whether cytokines generated in the lower female genital
tract originate with the cervical stroma or epithelium, the
host clearly has the ability to generate typical responses
to microbial challenges with resulting cytokine release and
subsequent cervical ripening and birth. But the question of
how these receptors and responses are regulated remains.
Progesterone was associated with decreased TLR-4 and TLR-
9 signaling in macrophages [49, 50]. In a study of human
tissues, TLR-2 and TLR-4 increased during pregnancy, and
TLR-2 was especially elevated in labor [51], and treatment
with medroxyprogesterone acetate decreased the ability of
lipopolysaccharide to trigger a cytokine response. This eﬀect
may involve macrophages [50] but would not exclude
cytokine downmodulation in other tissues, and the eﬀect
may be mediated rather than a direct eﬀect on the TLR
expression. Additional work is warranted to understand how
these factors operate in preterm compared to term birth.
7. CervicalInﬂammatory Reactions and
Preterm Birth
Current medical literature repeatedly states that inﬂamma-
tionistheﬁnalcommonpathwaytoparturition.Inconsider-
ing what inﬂammatory activities are relevant to this concept,
however, it is important to note that mechanistic details
may diﬀer with the gestational age at which preterm birth
occurs, and there may be unique characteristics associated
withinﬂammationthatiscenteredintheplacentaversusfetal
membranes or the cervix. And current concepts emphasize
that inﬂammatory reactions associated with preterm birth
do not have to be focused in the generative tract tissues.
For example, the inﬂammation associated with periodontitis
during pregnancy has been linked to the risk of prematurity
according to a recent review of more than 100 clinical
studies [52]. The association of urinary tract infection
and asymptomatic bacteriuria with low birthweight is well
established [53], and even the fetus may participate in the
inﬂammatory processes prior to birth [54]a si l l u s t r a t e db y
the fetal inﬂammatory response syndrome. Thus, while the
focus of this paper is on the cervix and its responses to
progesterone, the inﬂammatory reactions occurring at the
time of parturition may exert eﬀects in a variety of tissues.
As an example, a study performed in pregnant mice treated
intraperitoneally with low-dose lipopolysaccharide showed
elevated cytokine levels in the maternal serum, but later, the
cytokines appeared in the uterus, placenta, fetal membranes,
and fetal serum [55].
While the literature on cytokine expression in relation-
ship to preterm birth has grown substantially over the past
decade, it is important to point out in relationship to the
mechanism of preterm birth that the excursions in cytokine
concentration are probably neither the ﬁrst cause nor the
ﬁnal mechanism for delivery at the level of the cervix,
uterus, or placenta. A recitation of the studies measuring
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term and preterm labor and delivery is not needed here. It
will suﬃce to mention that a recent review [56] identiﬁed
increased levels of Il-6, Il-8, Il-1β,a n dT N F α as associated
with preterm birth, though the review also emphasized
inconsistencies that remain in the literature. Thus, cytokines
along with other biomolecules may most accurately be
portrayed as indicators of the induction of the inﬂammatory
cascade.
If the cytokines serve as biomarkers, the natural question
that follows is how they may support understanding and
prediction of the clinical outcomes that may be imminent.
One study indicated that IL-6 along with the other inﬂam-
matory marker C-reactive protein (CRP) levels predicted
that a baby was more likely to be born with sepsis and
that the time to delivery was related to these factors as
well [57]. Elevated Il-8 obtained from amniotic ﬂuid was a
correlate of intra-amniotic microorganisms and histologic
chorioamnionitis [58], and similarly, bacterial 16s ribosomal
RNA was found in placentas of women who had elevated
Il-6 and Il-8 [59]. While cord blood Il-8 was elevated
in cases of funisitis and both Il-6 and Il-8 were present
with histologic chorioamnionitis, the inﬂammatory marker
MMP-8, a leukocyte collagenase, was not correlated [60].
Further detail about outcomes was reported recently when
elevated maternal CRP and Il-6 but not MMP-9 were linked
both with prematurity before 32 weeks and intraventricular
hemorrhage in the infant.
While CRP and leukocytosis represent inﬂammatory
markers linked to preterm birth in addition to interleukins,
additional factors are also reported as being associated with
pretermbirth.Thus,macrophageinhibitoryfactor(MIP)has
been associated with preterm birth [61] as were decreased
levels of placental growth factor [62].
If early cytokine elevation serves as a biomarker for
preterm birth, then cytokine origin deserves consideration.
Cellular upregulation of cytokine expression is usually the
result of cellular (surface or cytoplasmic receptor) compo-
nents of the innate immune system that recognize pathogen-
associated molecular patterns. These PRRs (pathogen recog-
nition receptors) engage signaling cascades that result in
cytokines that recruit leukocytes or activate cells of the
immune system. Thus, microorganisms may be the initiating
factor for proinﬂammatory cytokine production, but they
are not the only source of cytokine generation.
A cognate concept of PAMPs which are microbial-
focused recognition systems is the DAMP or damage-
associated molecular pattern that may play a role in recog-
nition of endogenous molecules which have undergone
alteration through processes such as necrotic damage or
oxidation [63, 64]. The DAMP engages adapter molecules
that can then activate signal transduction pathways. The role
of speciﬁc adapter molecules RAGE (receptor for advanced
glycation endproducts) and HMGB-1 (high mobility group
box protein 1) has been examined in relationship to cervical
ripening recently [65] and provides a potential clue about
activation of inﬂammatory cascades in the absence of a
microbial trigger.
Since proinﬂammatory cytokines do not represent the
ultimate step in parturition, it is appropriate to note the
downstream eﬀects of these molecules. Increases in Il-6
and Il-8 at the cervix are associated with eﬀacement [66].
In addition, TNFα and inﬁltrating leukocytes [67], are
elevated in the ripening cervix, and ICAM (intercellular
adhesionmolecule)isoverexpressedinvascularendothelium
in preterm birth [68]. The cytokines expressed locally are
involved in complex interactions with prostaglandin and
nitric oxide which is considered to be a ﬁnal mediator in the
cervical maturation process [69].
Evidence has been presented that in the rodent uterus
TLR-4 signaling after lipopolysaccharide binding induces
MAP kinase signaling resulting in cyclooxygenase 2 (Cox
2) and intracellular phospholipase A(2) induction along
with a number of other inﬂammatory proteins through
Nf-κB mediated transcription [70]. Interestingly Dubicke
et al. found that rapid functional progesterone withdrawal
by mifepristone treatment of mice upregulated Pgts1 (Cox
1) [40]. Also in pregnant mice, lipopolysaccharide induced
prostaglandins (PGs) and nitric oxide (NO) in tandem and
inhibitors diminished both PG and NO as well as birth [71].
But the same report also indicated that NO increased or
decreased PG levels according to the NO concentration in
direct relationship. Despite the similar kinetics of NO and
PG, theyeachmay have distinct activities in theuterusversus
cervix and may be diﬀerently regulated [69, 72].
The majority of the discussion related to cervical inﬂam-
matory reactions and term and preterm birth have centered
on the proinﬂammatory cytokines with emphasis primarily
focusing on IL-1α TNFα, Il-6, and Il-8, and the modulation
of cytokine-mediated biological activity may occur through
the anti-inﬂammatory cytokines. The current literature
has tended to elevate Il-10 as the most signiﬁcant anti-
inﬂammatorycytokineinrelationtopretermbirthtodate.In
mouse pregnancy, preterm birth tended to be characterized
by increased levels of several proinﬂammatory factors, while
there was a downregulation of Il-10 [73]. Likewise in
chorionic villous cultures from early miscarriages, Il-10
was attenuated while IL-1a and Il-6 were elevated [74]. In
the presence of intra-amniotic infection at term, there was
a higher level of amniotic ﬂuid Il-10 than among term
pregnancieswithoutinfection,andinbothtermandpreterm
birth, the Il-10 was elevated [75] which on the surface seems
counterintuitive but may reﬂect a feedback mechanism to
dampen the proinﬂammatory reaction after parturition. A
large-scale evaluation of cord blood cytokines in preterm
and term birth showed elevations Il-10 at the same time Il-
2, 4, 5, and 8 along with MCP-1, MIP1α and β,soluble Il-6
receptor a, TNFα, soluble TNFα and TREM-1 which were
also elevated [76].
Another approach to examining inﬂammatory mod-
ulation has been to experimentally use substances that
antagonize pro-inﬂammatory cytokines. A study involving
75 women with recurrent spontaneous abortion showed
improved live birth rates when etanercept or adlimumab
were added to a regimen of anticoagulant and IVIG [77].
Though not having direct clinical application, a study of
placental explants challenged with bacterial components
(lipolysaccharide or lipoteichoic acid) showed elevation
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cytokines and Prostaglandin E(2) when Il-10 was added to
the incubation medium (78 19821803).
Recognizing that there are other anti-inﬂammatory
factors, some investigators have established balance sheets
that attempt to determine if broad panels of cytokines favor
pro- or anti-inﬂammatory cytokines. One report indicated
a 7-fold increase in preterm birth (before 34 weeks) risk
when a high inﬂammatory to anti-inﬂammatory ration was
detected [78]. Other studies agree, indicating that most
pro-inﬂammatory cytokines are increased in preterm birth,
while anti-inﬂammatory cytokines are decreased [79], and
speciﬁcally in the cervix the pro-inﬂammatory versus anti-
inﬂammatory score predominated [80].
Before leaving the topic of the interplay between pro-
and anti-inﬂammatory cytokines, brief mention should be
made regarding the genetic background of individuals that
could contribute to adverse pregnancy outcomes. Gene
polymorphisms have been identiﬁed in structural genes of
inﬂammatory factors or their receptors which can lead to
defectivebioactivemoleculesorevencompleteabsenceofthe
gene product. In addition, many single-nucleotide polymor-
phisms located in gene promoter regions of inﬂammatory
cytokines have been identiﬁed which can alter the regulation
and hence the response to normal stimuli [81, 82]. In the
present context, the ﬁnding that several polymorphisms in
the gene for Il-10 receptor were associated with the concen-
tration of IL-10 in the cervix suggests that both feedback
and feed-forward arms of the inﬂammatory cascade will
probably be important for cytokine expression, but crosstalk
between cytokines and other biologically active compounds.
A mutation in fetal Il-10 (-1082A) was associated with
infection-related preterm birth [83] as were other gene
polymorphisms in mother and fetus. As we have seen in the
past few years, the complexity of these regulatory networks is
continuing to be elucidated, and additional nuances of these
networks are being discovered.
8. Progesteroneandthe InﬂammatoryCascade
At the outset of this paper, two concepts were mentioned.
First, inﬂammation is involved as a common pathway in
birth, and second, progesterone (endogenous or exogenous)
is one of the most consistently eﬀective compounds in
maintaining pregnancy, namely, averting the initiation of
the common pathway of labor. The two concepts now come
together in the following paragraphs.
Progesterone has often been described as having
immune-suppressive activity and from a teleological point
of view, this makes sense as the mother’s immune system
needs to be tilted toward tolerance to host the fetal allograft.
Recent reviews have noted that the presence of sex steroid
receptors in innate immune cells such as macrophages or
lymphocytes, is well recognized [84], but innate immune
responses also involve epithelial and stromal cells such as
those found in the cervix. Smooth muscle was able to
act both as contractile cells and innate immune cell as
stimulation of smooth muscle cells (uterine and cervical)
with IL-1β showed through microarray-based analysis that
38 inﬂammation and immunity genes were stimulated [85].
Sex steroids aﬀect both immune and epithelial cells and are
able to elicit various growth factors from stromal cells [86].
Progesterone does not act in isolation from other steroid
and peptide hormones, and its activities are made more
pleotropic as a result of the fact that it has biological
activity resulting from traditional gene level activation
through steroid response elements on steroid hormone-
regulated genes, but also nongenomic activities mediated by
membrane receptors which engage in G-coupled signaling
cascades. Many of the interactions with the innate immune
system, and by extension, term and preterm parturition
appear dependent on this non-genomic mode of cellular
activation.
Adding to the complexity and hence the lack of absolute
clarity in the precise mechanism of progesterone action on
the immune system is the fact that some of the activities
of progesterone are systemic and some are local. For
example, a study of 17β-OH steroid dehydrogenase which
converts estradiol to the less estrogenic estrone and 20α-OH
progesterone to the more active progesterone showed that
at parturition, this enzyme was downregulated in endocer-
vical cells allowing for a localized functional progesterone
withdrawal [87]. Studies of isolated cells have the beneﬁt of
examining the eﬀects of compounds added to cell cultures
on the biology of those cells but have the simultaneous
disadvantage of not showing what happens when those
same cells are integrated into multicellular organ systems.
MAP Kinase signaling cascades have been demonstrated
as characteristic for the cervical ripening process [88]
in humans. The introduction of 17α-hydroxyprogesterone
caproate treatment randomly assigned to pregnant women
decreased cervical shortening after 21 days and decreased IL-
1b but did not aﬀect Il-6, Il-8, TNFα,o rn i t r i co x i d e[ 89].
These studies raise the question of whether progesterone
aﬀects the traﬃcking or maturation of inﬂammatory cells
which produce inﬂammatory cytokines and chemokines, or
whether the eﬀects occur more immediately on the cell level
processes that elicit the inﬂammatory mediators. Given the
pleotropic nature of the progesterone, it is likely that a long
list of direct and mediated eﬀects can be described.
In a pregnant rat study [90], normal pregnancy pro-
ceeded with decrease in inducible nitric oxide synthase and
an increase in COX-2. But with progesterone inhibition
(onapristone), expression of both enzymes increased as
premature birth was initiated. There is reason to believe
that these eﬀects could at least be partly explained by
progesterone eﬀects on inﬂammatory cells. Dubicke et al.
and coworkers [40] characterized the cellular inﬁltrates
during parturition induced by progesterone withdrawal
(mifepristone) or lipopolysaccharide and showed that the
latter induced a neutrophil response and the former favored
a monocytic response. Thus, the eﬀects of progesterone may
also depend on the mechanism initiating inﬂammatory reac-
tions. In another study involving 17α-hydroxyprogesterone
caproate, treatment did not aﬀect basal levels, but with
stimulation by lipopolysaccharide or lipoteichoic acid, Il-6
was elevated, whereas progesterone-treated subjects did not
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The possibility that some of the eﬀects of progesterone
are initiated by eﬀects on inﬂammatory cells is suggested
by the ﬁnding that progesterone can modify TLR signaling.
Macrophages treated with progesterone had diminished
responses to stimuli that act through TLR4 and TLR9 [49,
50] with decreased IL-6, and iNOS, and TLR4 expression. In
lipopolysaccharide-stimulated macrophages, progesterone
treatment increased expression of SOCS-1 (suppressor of
cytokine signaling-1), suggesting a possible mechanism for
the progesterone eﬀect. This is in consonance with an earlier
observation that progesterone decreases mouse macrophage
nitric oxide [92].
Progesterone is responsible for interactions with leuko-
cytes which elaborate progesterone-induced blocking factor
[93] which has immunomodulatory functions. Activated
pregnancy lymphocytes have membrane receptors for pro-
gesterone, and the action of PIBF under control of proges-
terone increases Th2 type signaling by a novel Il-4 receptor
that in mouse studies activated the JAK/STAT signaling
pathway [94] accompanied by a decrease in phospholipase
A2 which decreases prostaglandin production. Although
studied extensively in mice, PIBF is also produced in human
pregnancy,anditseﬀectsareconsistentwithbeneﬁcialeﬀects
on continuing gestation.
The possibility that progesterone exerts eﬀects on the
immune network at a central regulatory level is suggested
by studies that indicated T-regulatory cells (CD4+ CD25+)
are increased peripherally and in the uterus of progesterone-
treated mice [95] and by a study in humans that found
T-regulatory cells were upregulated in the midtrimester.
These regulatory cells suppressed Il-2, TNFα, and gamma
interferon, while upregulating Il-4 and Il-10 in responder
cells.
Progesterone eﬀects on the immune network have been
noted in a number of studies going back many years.
Progesterone has been associated with inhibitory eﬀects
on T cells, macrophages, and natural killer cells [96].
Normal, uncomplicated pregnancy shows a decrease in
proinﬂammatory cytokines as pregnancy progresses, and
increasinganti-inﬂammatoryfactorsisindicativeofimmune
regulation in the physiologic adaptation to gestation [97].
Th2 cytokines are favored by normal pregnancy [98], and a
study a herbal traditional medicine treatment for threatened
abortion showed a shift from Th1 to Th2 responses with a
correlation with Il-10 [99].
Keeping the focus of this paper on the role of the
cervix and its interaction with progesterone, it is impossible
to ignore the important activities it has in maintaining
uterine quiescence and eﬀects on myometrial activity, or the
interaction with the inﬂammatory activity at the decidual
interface between mother and fetus. Eﬀects on vascular
endothelium, also mediated through inﬂammatory factors
relative to uterine blood ﬂow, have been a topic of interest
for researchers and in some instances help inform the
possible actions in the cervix during pregnancy. Indeed,
many of the non-genomic eﬀects of progesterone have been
discovered through studies of the uterus rather than the
cervix. Many of the non-genomic eﬀects of progesterone
(and estrogen) have been focused on the potential role of
hormones in cancer and metastatic processes. These various
other attributes of progesterone have proved important in
recognizing that cell surface receptors for progesterone can
transducesignalsthroughtheMAPkinasepathwayincluding
vascular functions [100, 101]. Evidence of progesterone
signaling was reported in breast cancer research [102]. More
directly related to the focus on the cervix, MAP kinase
signaling by progesterone was able to aﬀect the expression of
extracellular matrix-related integrin synthesis which clearly
has implications for the cervical ripening process [103]. The
ultimateexpression offactorsinducedbysignaltransduction
will involve nuclear transcription factors, and in this regard,
it is notable that progesterone was found to suppress the NF-
κB expression resulting in depressed cytokine levels [104].
The complexities of progesterone activities biological
mechanisms related to pregnancy and parturition have
not been exhaustively reviewed here, but it is clear that
there are several mechanisms known to be consistent with
the forestalling of parturition. However, additional details
continue to be uncovered. For example, progesterone aﬀects
monocytes at the earliest level of pregnancy through means
of glycodelin which has been recently reviewed and has
activities that may contribute to the Th2 dominance in
pregnancy [105]. While glycodelin A was studied in relation
to implantation, its eﬀect on MMP2 and MMP9 may
be of importance to the prevention of untimely cervical
ripening. Glycodelin A has been identiﬁed in 11 of 14
archival specimens of cervical epithelium [106], but its role
in the pregnant cervix is only conjectural at present. Thus,
the understanding of the precise role of progesterone in
support of pregnancy and the details as expressed in various
tissues will only continue to become more complex as its
multiplicities of function are investigated.
9. TranslationalImplications
A substantial body of scientiﬁc knowledge has been built
around the concept that the uterine cervix serves a physical
support function for the gravid uterus changing from a rigid
to a pliable structure at the time of delivery. But in the
absence of information that brings some practical value to
the extensive research reported here, the understanding of
thephysiology,cellularbiology,andenvironmentaleﬀectson
cervical function will be strictly academic.
The structural role of the cervix, like other structures, is
onlypartofthestory.Thesofteninganddilationofthecervix
is a biological process timed intricately, coinciding with the
uterinecontractionsthatmovethefetusintoandthroughthe
birth canal. This can, and too often does, occur prematurely.
Sometimes, the biological characteristics recede into the
background as the structural properties of the cervix assume
the central focus. In the case of multiple births, cervical
dysfunctionseemslargelyamatterofstructuralsupport.The
same is also true when cervical dysfunction is secondary to
previous LEEP procedure. Despite the conceptual potential
value of cerclage in support of the structural function,
the role of cerclage has not proved uniformly successful,
and in evidence-based medicine studies, its use has limited
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The fact that cerclage is not uniformly successful in
preventing premature cervical ripening and delivery attests
to the fact that biological processes are also at work. The
process of parturition engages many of the mediators and
consequences of inﬂammation, and these have profound
eﬀects on the uterus and the cervix. We emphasized that
within the cervix the inﬂammatory cascade is highly active
during cervical ripening and involves inﬂammatory cells and
mediatorswhichleadtoremodelingofthetissue.Theprocess
leads to increased tissue compliance through alterations in
extracellular matrix coupled with proteolytic action in the
tissue and ﬁnally with the production of prostaglandins and
nitric oxide which are the ﬁnal steps in a cascade process.
Since we recognize the ﬁnal pathway to birth as a cascade
process, it may not matter what speciﬁc event triggered the
ﬁnal stages of cervical ripening, labor, and delivery as the
process is likely to proceed despite tocolytic drugs although
delivery might be delayed slightly to allow for antenatal
steroid use.
The ability to determine the presence of a shortening
of the cervical canal has created a new means of predicting
the likelihood of engaging the inﬂammatory process prema-
turely. This ﬁnding of a physical change in the geometry of
the cervix can be related to the mechanism of prematurely
engaging the inﬂammatory process at least theoretically
because of the partial disruption of cervical mucus and
the movement of the bacterial ﬂora into closer proximity
to the endocervical epithelium and its unique display
of bacterial recognition receptors and to the fetal mem-
branes where infection and inﬂammatory processes may
arise.
The signiﬁcance of the shortened cervix has its trans-
lational application in the duality represented by structural
compromise coupled with physiologic changes. Therefore,
clinicians have considered both structural and pharmaco-
logic approaches to the short cervix. Cerclage addresses the
advancing compliance of the tissue, and progesterone has
beenintroducedbecauseofitsdemonstratedutilityatleastin
a percentage of cases of impending preterm labor. The most
recent compilation of the evidence for use of progesterone
[108] concludes that progesterone helps prevent birth before
32 weeks and has beneﬁts for newborn mortality and
respiratory distress syndrome and necrotizing enterocolitis.
We have attempted to document the multiple levels
at which progesterone aﬀects the cervical biology in a
variety of ways that promote the prolongation of pregnancy.
Unfortunately, the scientiﬁc explanation of all of the eﬀects
of progesterone at the level of the cervix has not been
established, but suﬃcient understanding is available to
appreciate how this intervention may reduce the likelihood
of adverse outcomes, although as many structured reviews
have stated, the literature does not yet contain studies that
adequately address all the practice questions related to the
use of progesterone including adverse metabolic eﬀects on
mother and fetus.
Microorganisms may be the genesis of inﬂammatory
reactions leading to preterm birth, and several investigators
in large and small studies have sought the translational
application of this fact in the hypothesis that antibiotics
should prevent prematurity. However, evidence reviewed
in 2007 did not show that antibiotic treatment of at risk
women prevented preterm birth [109]. A diﬀerent paper
[110] concluded that macrolide or clindamycin given in
the second trimester to women at risk for preterm birth
did lower their risk of delivering prematurely but metron-
idazole increased risk. Once membranes were ruptured
prematurely, the introduction of antibiotic treatment while
not preventing premature birth provided several beneﬁts
including greater likelihood of delivering later than 48 hours
after membrane rupture, and decreased chorioamnionitis
[111]. The science suggesting that preterm birth is part
of a cascade suggests that antibiotics are unlikely to alter
the course of the inﬂammatory cascade once it has been
initiated.
Another lesson implied by the concept of inﬂammation-
related cascades as the trigger for initiation of parturition is
that we need to develop a better understanding of how to
manage the trigger. Antibiotics in general terms represents
a blunt instrument, and simply introducing antibiotics
broadly into obstetric care cannot be expected to be eﬀective
as the literature has demonstrated. Every pregnant woman
carries an abundant ﬂora, and the ﬂora diﬀers among
individuals. Some of the organisms found commonly in
the ﬂora have a reputation as harmful, and yet eliminating
these organisms has not had an eﬀect on prematurity [112].
Individuals will also have unique genetic backgrounds that
are only beginning to be related to their immune responses
to diﬀerent microorganisms. We are still in the process of
discovering microorganisms present in the normal ﬂora that
cannot be cultivated, but only detected through molecular
methods. In addition, we still struggle with the urge to
identify every organism as a pathogen or nonpathogen,
which is an artiﬁcial and sometimes counterproductive way
of looking at microorganisms. Based on better methods for
unraveling the complexity of host-microbe interactions, new
molecular targets will be developed in the future.
In this paper, we have also noted that recent research
suggests that there are diﬀerences in some of the mecha-
nistic details between birth that is related to progesterone
withdrawal versus birth precipitated by bacterial triggering
of virulence pattern recognition receptors such as TLR or
NOD molecules. Continued research may identify useful
targets in these pathways, but interestingly, information
suggesting that progesterone may modulate the terminal
steps in the delivery cascade (prostaglandin and nitric oxide)
suggests that the role of progesterone may increase in the
future, depending on the outcome of well-designed and
appropriately powered studies to investigate eﬃcacy, closely
deﬁned populations for study, and investigation of adverse
eﬀects in mothers and their infants after administration
of pharmacologic interventions. Translational research will
continue as an outgrowth of the science that identiﬁes novel
targets for interdicting preterm birth, but devising safe and
meaningful research that provides useful evidence that truly
informs clinical practice will be a challenge as investigators,
clinicians, and funding agencies wrestle with deciding which
approaches are most appropriate and promising for clinical
trials.10 Infectious Diseases in Obstetrics and Gynecology
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